Pre-Conference Workshops: Monday, March 16th, 2026 - ET (Eastern Time, GMT-05:00)
Attendees Choose Between 3 Pre-Conference Add-On Workshops (A-C)
Identify upcoming legislative and regulatory changes most likely to impact patient support programs and access initiatives
Understand how policy changes are viewed differently by government, industry, and patient advocacy organizations
Develop strategies to anticipate and prepare for policy shifts before they disrupt patient access
- Aaron Winn - Associate Professor, University of Chicago
- Mike Eging - Leadership Team, Rare Access Project
- Melissa Horn, MPA - Director of State Legislative Affairs, Arthritis Foundation
- Ulrich Neumann - Director, Access & Policy Research, Johnson & Johnson
Understand how Medicare drug price negotiations reshape patient assistance program design and eligibility requirements
Leverage premium smoothing provisions to enhance affordability while maintaining program sustainability
Adapt patient support services to align with Part D benefit restructuring and out-of-pocket caps
- Corey Ford - Principal, Nuvera, an Inizio Engage Company
Before we can solve problems, we need to name them. This interactive session surfaces the repetitive tasks consuming your team's capacity and quantifies the hidden costs.
Collaborate with pharma and hub peers to identify the highest-volume, lowest-value tasks draining your resources
Calculate the true cost of manual processes using numbers from your own operations
Map common pain points across the patient access journey and discover how similar your challenges are whether you sit on the manufacturer or hub side of the table
No technical background required. This workshop assumes participants are new to AI tools and builds understanding from the ground up through demonstration and hands-on experience. Please bring a laptop to participate fully in the hands-on exercises.
- Kshitij Gupta - Co-Founder and CEO, 100ms
- Aniket Behera - Co-founder, COO, 100ms
- Anubhav Srivastava - Head of Revenue, Sales, 100ms
- Naresh Aggarwal - Founders Office, 100ms
The best way to learn is by doing. This session opens with a live demonstration, then puts the controls in your hands to work with AI tools using data your team sees every day.
Get hands-on with live AI tools
See how the technology interprets responses and handles exceptions
Push the limits - test the AI with your toughest scenarios
No technical background required. This workshop assumes participants are new to AI tools and builds understanding from the ground up through demonstration and hands-on experience. Please bring a laptop to participate fully in the hands-on exercises.
- Kshitij Gupta - Co-Founder and CEO, 100ms
- Aniket Behera - Co-founder, COO, 100ms
- Anubhav Srivastava - Head of Revenue, Sales, 100ms
- Naresh Aggarwal - Founders Office, 100ms
Implement a strategic timeline for engaging market access, trade, patient services, field teams and pricing/contracting stakeholders at optimal pre-launch intervals
Develop effective distribution models through collaborative planning between commercial and trade colleagues
Create frameworks for assessing market and payer challenges that inform contracting strategies and access planning
- Manishi Prasad - Vice President, Market Access and Government Affairs, Beam Therapeutics
- Jeffrey Vernice - Director, Patient Excellence, Boehringer Ingelheim Pharmaceuticals, Inc.
- Kristen Reilly - Senior Director, Strategic Insights & Access Analytics, Azurity Pharmaceuticals
Design patient identification approaches that scale appropriately from the focused rare disease setting to broader specialty markets
Implement competitive positioning tactics that account for different stakeholder landscapes and treatment alternatives
Create resource allocation models that optimize investment across the different demands of rare and mainstream therapeutic areas
- Jessica Longo, Commercial Marketing Leader
- Mary Lou Szekeres - Senior Director Market Access Strategy and Marketing, Geron Corporation
- Ashar Hasan - CEO, Medmonk
- Richard Fahrer - Oncology Marketing Director - Patient Solutions, Pfizer
Explore how the Big Beautiful Bill (BBB) and new administration priorities transforms the patient support landscape, requiring innovative approaches to ensure continued access
Develop contingency plans for the revived Most Favored Nation drug pricing model and its impact on patient affordability
Master the changing Medicaid/Medicare landscape to serve dual-eligible populations
- Mike Eging - Leadership Team, Rare Access Project
- Alex Meixner - Vice President, State Policy, ALS Association
Explore the impact of GLOBE and GUARD on patient access and rare disease pipelines
Discuss the rapidly changing MFN policies and their effects on U.S. and global access
Examine strategies to address challenges and opportunities for patients
- Jennifer Snow - Founder, Apteka
- Ashira Vantrees, Esq. - Director of Legal Strategy and Advocacy, Aimed Alliance
No technical background required. This workshop assumes participants are new to AI tools and builds understanding from the ground up through demonstration and hands-on experience. Please bring a laptop to participate fully in the hands-on exercises.
- Kshitij Gupta - Co-Founder and CEO, 100ms
- Aniket Behera - Co-founder, COO, 100ms
- Anubhav Srivastava - Head of Revenue, Sales, 100ms
- Naresh Aggarwal - Founders Office, 100ms
Now go deeper. Analyze the workflows that you prioritized earlier to identify where AI can deliver immediate impact and where human judgment remains essential.
Map your priority high-volume workflows, distinguishing rules-based tasks from judgment-dependent decisions
Which processes are ready today? Which should remain human?
Build a 60-second business case pitch you can present to leadership
No technical background required. This workshop assumes participants are new to AI tools and builds understanding from the ground up through demonstration and hands-on experience. Please bring a laptop to participate fully in the hands-on exercises.
- Kshitij Gupta - Co-Founder and CEO, 100ms
- Aniket Behera - Co-founder, COO, 100ms
- Anubhav Srivastava - Head of Revenue, Sales, 100ms
- Naresh Aggarwal - Founders Office, 100ms
Ideas without action are just good intentions. Address the real barriers to adoption and leave with concrete next steps.
Confront concerns head-on: compliance, integration, and change management
Evaluate three implementation pathways - pilot programs, hub partner requirements, and internal capability building
Complete your Personal Action Plan: one next step, one conversation, one 30-day goal
No technical background required. This workshop assumes participants are new to AI tools and builds understanding from the ground up through demonstration and hands-on experience. Please bring a laptop to participate fully in the hands-on exercises.
- Kshitij Gupta - Co-Founder and CEO, 100ms
- Aniket Behera - Co-founder, COO, 100ms
- Anubhav Srivastava - Head of Revenue, Sales, 100ms
- Naresh Aggarwal - Founders Office, 100ms
Identify and evaluate the primary post-launch therapy barriers of access, affordability, copay burden and adherence across the patient journey
Design automated, coordinated workflows that align benefit verification, prior authorization and enrollment processes to reduce delays and administrative friction
Develop monitoring and governance frameworks that combine real-time affordability visibility with early risk detection to sustain long-term performance
- Dhiren Patel - Partner, Taurus Health
- Mark Beightol - Executive Vice President, Client Services, MedMonk
- Tina Valbh R.ph, B.S Pharm, - Co-Founder, Tina's Warriors, a Patient Advocacy Nonprofit
- Jugal Shah, MHA - Manager, Patient Services, Octapharma USA, Inc.
Pharmacy-delivered brand launches face growing affordability risk from opaque benefit designs and payer strategies that quietly erode access and margin. This session examines how embedding a consent-driven patient engagement layer from day one gives manufacturers real-time visibility into affordability, flexibility across copay and hub vendors, and control over evolving benefit strategies without disrupting patient care.
Design affordability into launches instead of fixing it later
Gain visibility into copay utilization and maximizer impact
Preserve vendor and benefit flexibility without patient disruption
Align patient access with sustainable gross-to-net performance
- Patrick Coyle - na, GTN Thought Leader
**Open to pharmaceutical and biotech manufacturers only. Attendance is at the discretion of Informa and Inizio Engage.